Comparative cost-effectiveness analysis of quinidine, procainamide and mexiletine.

@article{Podrid1991ComparativeCA,
  title={Comparative cost-effectiveness analysis of quinidine, procainamide and mexiletine.},
  author={Philip J. Podrid and Peter Russell Kowey and William H. Frishman and Robert J. Arnold and Diana J. Kaniecki and J. Robert Beck and Joni R. Beshansky},
  journal={The American journal of cardiology},
  year={1991},
  volume={68 17},
  pages={
          1662-7
        }
}
Cost‐Effectiveness of Antihypertensive Agents in Patients With Reduced Left Ventricular Function
TLDR
A pharmacoeconomic primer reviews current economic models used to analyze and synthesize information that may be considered in certain health‐related policies or clinical decisions and suggests cost‐effectiveness analyses may be an appropriate method to evaluate these effects and facilitate the identification of a regimen that minimizes deterioration of LV function.
Pharmacoeconomic Considerations in Antiarrhythmic Therapy
TLDR
It is uncertain whether pharmacotherapy is more cost-effective than other strategies and whether initial therapy with one agent is preferable to that with another when efficacy, incidence of adverse effects and costs of treating these adverse effects are examined.
A stochastic approach to the pharmacotherapeutic management of chronic moderate adult asthma
TLDR
Even though the inhaled beta2-agonist agent and sustained-release theophylline protocol had the lowest maintenance medication costs, it also had the highest cost-effectiveness ratio, suggesting it is the least desirable therapy when associated hospital services are included in the costs.
Cost-Benefit Analysis of Physician Assistants
TLDR
This study affirms that PAs are not only cost-effective from a labor standpoint but are also cost-beneficial to those who employ them and suggests that PA employment should be expanded in many sectors of the health care system.
Comparative cost-effectiveness analysis of theophylline and ipratropium bromide in chronic obstructive pulmonary disease. A three-center study.
TLDR
Treatment with IB was less costly and more cost-effective than T and predicted that patients receiving IB had a greater number of complication-free therapy-months than patients receiving T.

References

SHOWING 1-10 OF 20 REFERENCES
Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.
TLDR
It is concluded that neither encainide nor flecainide should be used in the treatment of patients with asymptomatic or minimally symptomatic ventricular arrhythmia after myocardial infarction, even though these drugs may be effective initially in suppressing ventricular arrhythmia.
Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.
TLDR
Quinidine treatment is more effective than no antiarrhythmic therapy in suppressing recurrences of atrial fibrillation but appears to be associated with increased total mortality.
Comparative cost effectiveness of gentamicin and tobramycin.
TLDR
An extensive sensitivity analysis--varying frequency and cost of nephrotoxicity, dialysis requirements, aminoglycoside acquisition costs, and length of hospitalization--showed gentamicin to be more cost effective than tobramycin, unless hospitalization is prolonged by an average of at least 15 days for patients with severe neph rotoxicity.
Management of acute dysuria. A decision-analysis model of alternative strategies.
TLDR
A decision-analysis model was developed to estimate the effects and costs of alternative initial management strategies for women presenting with dysuria and pyuria and found single-dose regimens were preferable to multiple- dose regimens of either drug, and trimethoprim-sulfamethoxazole was preferable to amoxicillin.
Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension.
TLDR
Propranolol appears to be the preferred initial option under most of a variety of alternative assumptions for antihypertensive medications in persons aged 35 through 64 years with diastolic blood pressure of 95 mm Hg or greater.
Cost-effectiveness of misoprostol for prophylaxis against nonsteroidal anti-inflammatory drug-induced gastrointestinal tract bleeding.
TLDR
It is concluded that misoprostol is costly as primary prevention for NSAID-induced gastrointestinal tract bleeding in the groups examined but may be cost-effective as secondary prevention in patients with a proved history of gastrointestinal tract bleed.
Formulary evaluation of third-generation cephalosporins using decision analysis.
TLDR
All current third-generation cephalosporins (cefotaxime, cefoperazone, and moxalactam) should be removed from the institutions's formulary and be replaced with ceftazidime and ceftriaxone.
Application of decision analysis to drug selection for formulary addition.
TLDR
Results show that ceftizoxime is the least costly treatment for hospital-acquired pneumonia and sepsis of unknown origin, whereas metronidazole plus gentamicin is the most costly regimen for intra-abdominal infections.
A comparison of statistical methods for combining event rates from clinical trials.
TLDR
Two statistical methods for combining event rates from several studies are compared and the presence of heterogeneity influences the conclusion that the DerSimonian and Laird modified Cochran method tends to be more conservative.
The Cardiac Arrhythmia Suppression Trial: Implications for Antiarrhythmic Drug Development
The results of the Cardiac Arrhythmia Suppression Trial (CAST) have had an immediate and profound impact on contemporary cardiology. The CAST promises to exert considerable influence on
...
...